COLLETTE NGANTE: Open Payments
NPI 1619331204 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,848 in 95 payments from 14 companies in 2025. Trend: 2023 $1,694 · 2024 $1,785 · 2025 $1,848
Food & beverage: $1,848
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 15 | $349 |
| Otsuka America Pharmaceutical, Inc. | 21 | $267 |
| Vanda Pharmaceuticals Inc. | 12 | $234 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $233 |
| ABBVIE INC. | 9 | $175 |
| Alkermes, Inc. | 7 | $152 |
| Janssen Pharmaceuticals, Inc | 3 | $104 |
| E.R. Squibb & Sons, L.L.C. | 4 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| Axsome Therapeutics, Inc. | 3 | $64 |
Products named: REXULTI, CAPLYTA, VRAYLAR, ARISTADA, FANAPT, COBENFY, HETLIOZ, INVEGA SUSTENNA.
Industry payments across VA — which companies pay providers there.
